Idiopathic pneumonia syndrome (IPS) is an acute lung dysfunction of non-infectious
aetiology and a severe complication following haematopoietic stem cell transplantation …

Our current knowledge of idiopathic pneumonia syndrome (IPS) predates improved
specificity in the diagnosis of IPS and advances in hematopoietic cell transplantation (HCT) …

Rationale: Acute lung dysfunction of noninfectious etiology, known as idiopathic pneumonia
syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation …

OBJECTIVE: To analyze extent and patterns of lung involvement in patients with idiopathic
pneumonia syndrome (IPS) following allogeneic stem cell transplantation (SCT), and …

Idiopathic pneumonia syndrome (IPS) is a serious complication after hematopoietic stem cell
transplantation. Despite the high mortality rate with medical management, there have been …

Newer diagnostic methods may link more idiopathic pneumonia syndrome (IPS) cases to an
infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell …

Idiopathic pneumonia syndrome (IPS) is a noninfectious pulmonary complication after
hematopoietic cell transplantation (HCT) and is difficult to diagnose. In 41 patients with IPS …

Idiopathic pneumonia syndrome (IPS) is a rare complication following stem cell transplant
(SCT) and its incidence among pediatric SCT recipients is not known. To assess the …

We retrospectively analyzed 23 cases with early‐onset idiopathic pneumonia syndrome
(IPS) of 192 patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) …

Idiopathic pneumonia syndrome is a rare complication following hematopoietic stem cell
transplantation (HSCT), defined by diffuse lung injury with no identified etiology, with an …